The European Society of Cardiology (ESC) Guidelines for the diagnosis and management
of acute pulmonary embolism (PE), developed in collaboration with the European Respiratory
Society (ERS), were updated in 2019. The European Journal of Internal Medicine has
published an elegantly written commentary by Vedovati and colleagues [
[1]
], highlighting and critically reviewing some of the new recommendations. This article
provides an excellent opportunity to explain and justify the main novelties and changes
in the updated version of the ESC Guidelines, and also to put the remaining unanswered
questions into perspective.Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Beyond the guidelines: novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism.EJIM. 2019;
- 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).Eur Heart J. 2020; 41: 543-603
- Age-adjusted d-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study.JAMA. 2014; 311: 1117-1124
- Simplified diagnostic management of suspected pulmonary embolism (the years study): a prospective, multicentre, cohort study.Lancet. 2017; 390: 289-297
- Diagnosis of pulmonary embolism: progress after many years.Lancet. 2017; 390: 210-211
- Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis.Eur Heart J. 2019; 40: 902-910
- 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Europace. 2016; 18: 1609-1678
- Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.Blood. 2018; 132: 1365-1371
- Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies.Vasa. 2019; 48: 483-486
- Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases.Eur Heart J. 2018; 39: 4196-4204
- Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor xa inhibitor rivaroxaban.Int Multicent Single-arm Clin Trial. Eur Heart J. 2019;
- Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D).J Clin Oncol. 2018; 36: 2017-2023
- Edoxaban for the treatment of cancer-associated venous thromboembolism.N Engl J Med. 2018; 378: 615-624
- Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH.J Thromb Haemost. 2018; 16: 1891-1894
- Apixaban versus Dalteparin for the treatment of acute venous thromboembolism in patients with cancer: the Caravaggio study.Thromb Haemost. 2018; 118: 1668-1678
- The dipep study: an observational study of the diagnostic accuracy of clinical assessment, d-dimer and chest x-ray for suspected pulmonary embolism in pregnancy and postpartum.BJOG. 2019; 126: 383-392
- Diagnosis of pulmonary embolism during pregnancy: a multicenter prospective management outcome study.Ann Intern Med. 2018; 169: 766-773
- Pregnancy-Adapted years algorithm for diagnosis of suspected pulmonary embolism.N Engl J Med. 2019; 380: 1139-1149
- The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.Eur Heart J. 2018; 39: 1330-1393
Article info
Publication history
Published online: February 19, 2020
Accepted:
February 12,
2020
Received:
January 28,
2020
Identification
Copyright
© 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
